The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 11, 2020

Filed:

Feb. 27, 2012
Applicants:

Ryan C. Bailey, Urbana, IL (US);

Brendan A. Harley, Urbana, IL (US);

Teresa A. Martin, Champaign, IL (US);

Steven R. Caliari, Urbana, IL (US);

Inventors:

Ryan C. Bailey, Urbana, IL (US);

Brendan A. Harley, Urbana, IL (US);

Teresa A. Martin, Champaign, IL (US);

Steven R. Caliari, Urbana, IL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61L 27/38 (2006.01); A61K 35/12 (2015.01); A61L 27/50 (2006.01); A61L 27/56 (2006.01); A61K 35/32 (2015.01); A61L 27/54 (2006.01); A61L 27/26 (2006.01); A61L 27/48 (2006.01); C08B 37/00 (2006.01); C12N 5/00 (2006.01); C12N 5/077 (2010.01); A61K 38/18 (2006.01); A61K 38/30 (2006.01);
U.S. Cl.
CPC ...
A61L 27/38 (2013.01); A61K 35/12 (2013.01); A61K 35/32 (2013.01); A61L 27/26 (2013.01); A61L 27/48 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61L 27/56 (2013.01); C08B 37/0063 (2013.01); C12N 5/0062 (2013.01); C12N 5/0654 (2013.01); C12N 5/0655 (2013.01); C12N 5/0657 (2013.01); C12N 5/0658 (2013.01); A61K 38/1858 (2013.01); A61K 38/30 (2013.01); A61L 2430/02 (2013.01); A61L 2430/06 (2013.01); A61L 2430/20 (2013.01); A61L 2430/28 (2013.01); A61L 2430/30 (2013.01); A61L 2430/32 (2013.01); A61L 2430/40 (2013.01); C12N 2533/54 (2013.01);
Abstract

The invention provides methods and compositions for making and using collagen-glycosaminoglycan three-dimensional scaffolds immobilized with biomolecules that are spatially and temporally patterned. The method comprises adding benzophenone to a collagen-glycosaminoglycan three dimensional scaffold in the dark; adding one or more biomolecules to one or more areas of the collagen-glycosaminoglycan three-dimensional scaffold (which can be done optionally in the dark or in the light); and exposing the collagen-2glycosaminoglycan three-dimensional scaffold to light at a wavelength of about 350 to about 365 nm.


Find Patent Forward Citations

Loading…